N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-γ sensitivity for apoptosis in human glioblastoma cells

This publication has 46 references indexed in Scilit:

• Mechanisms of Mitotic Cell Death Induced by Chemotherapy-Mediated G2 Checkpoint Abrogation
  Cancer Research, 2007
• The chromosomal passenger complex: guiding Aurora-B through mitosis
  Journal of Cell Biology, 2006
• Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
  Annals of Oncology, 2006
• Expression profiles of p63, p53, survivin, and hTERT in skin tumors
  Journal of Cutaneous Pathology, 2004
• The Survivin/Aurora B Complex: Its Role in Coordinating Tension and Attachment
  Cell Cycle, 2003
• Validating survivin as a cancer therapeutic target
  Nature Reviews Cancer, 2003
• pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide
  Oncogene, 2000
• Reduction of both RAR and RXR Levels Is Required to Maximally Alter Sensitivity of CA-OV3 Ovarian Tumor Cells to Growth Suppression by all-trans-Retinoic Acid☆
  Experimental Cell Research, 1997
• Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat
  European Journal of Cancer, 1997
• Growth Inhibition and Induction of Apoptosis by Fenretinide in Small-Cell Lung Cancer Cell Lines
  JNCI: Journal of the National Cancer Institute, 1995